Skip to main content
. 2018 Jun 12;108(1):188–200. doi: 10.1093/ajcn/nqy081

Figure 1.

Figure 1

Analysis scheme. Experiments, described in the leftmost column, proceeded from top to bottom. Cohort source and sample sizes for the various genotypes at APOA2 −265T >C under conditions of low or high SFA intake are given. For all analyses involving the BPRHS cohort, data from the same participants were used, and from the same data collection period. APOA2, apolipoprotein A-II; BPRHS, Boston Puerto Rican Health Study; FHS, Framingham Heart Study; GOLDN, Genetics of Lipid Lowering Drugs and Diet Network.